24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
cancer
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
14:51
Intel’s Israeli workforce hits decade low as more layoffs loom
10:55
As Israeli tech ecosystem matures, the meaning of exit evolves
10:28
"It’s important to plan the vision from the very beginning"
10:20
“Selling the product is the easy part. Convincing people to believe in you is the hard part”
More stories
Buzz
Most popular
Daily
Weekly
1
Intel says upcoming layoffs will be less than 20,000—but early retirement won’t be an option
2
"The best product doesn’t always win. Usually, it’s the product that is most effectively sold"
3
Lightrun raises $70 million to bring AI-powered real-time remediation to enterprise software
4
Unicorn Augury cuts 18% of workforce in second round of layoffs
5
After evasion allegations, Deel accepts service in Rippling lawsuit
More news
cancer
2 stories about cancer
Meet Kite Pharma's CEO, the Man Bringing Hope to Hodgkin's Lymphoma Patients
30.08.17
|
Dror Reich
With two exits worth hundreds of millions of dollars to his name even before selling Kite Pharma for $12 billion dollars, just where will Arie Belldegrun aim next?
Gilead To Buy Kite Pharma for $11.9 Billion
29.08.17
|
Dror Reich
The drug company is looking to diversify into cell therapy following declining hepatitis c drug sales